查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1999159

生物製程容器市場：2026-2030年全球市場預測（按容器類型、材質、容量、滅菌方法、應用和最終用戶分類）

Bioprocess Containers Market by Container Type, Material, Capacity, Sterilization Method, Application, End User - Global Forecast 2026-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年生物製程容器市場價值為 60.9 億美元，預計到 2025 年將成長至 74 億美元，複合年成長率為 22.33%，到 2030 年將達到 204.4 億美元。

主要市場統計數據
基準年 2024 60.9億美元
預計年份：2025年 74億美元
預測年份 2030 204.4億美元
複合年成長率 (%) 22.33%

本簡要概述面向決策者，說明了生物製程容器在確保製程完整性、法規遵循和營運擴充性不斷變化的作用。

生物程序容器的現狀正處於兩大趨勢的交匯點：快速的科學進步和日益嚴格的營運監管。隨著生物製藥研發和生產的不斷發展，容器不再只是被動的容器，而是成為保障製程完整性、污染控制和供應鏈韌性的關鍵要素。這些容器支援從小規模科學實驗到大規模契約製造的各種活動，其選擇會影響工藝的可重複性、驗證計劃和下游物流。

關鍵的結構和技術變革正在重塑生物製程容器使用中的供應商動態、材料優先事項和監管預期。

在生物製程容器領域，正在發生多項變革性變化，這些變化正在重新定義供應商關係、設計優先順序和採購邏輯。首先，向一次性系統和混合製程的加速轉型迫使製造商和整合商優先考慮組件相容性、連接器標準化和供應連續性。這種演變正在重塑製藥開發商進行製程轉移和技術合格的方式，並對驗證策略和供應商審核產生連鎖反應。

2025 年的關稅趨勢將如何重新評估整個生物製程容器價值鏈的採購選擇、供應商選擇要求和供應鏈彈性策略？

已發表的2025年關稅措施和貿易政策變化對生物製程容器生態系統產生了多方面的影響，包括採購決策、成本結構和供應商選址規劃。對於依賴跨境供應鏈的企業而言，關稅上調將提高進口零件和成品容器的實際接收成本，從而擠壓利潤空間，迫使買家重新審視其供應商選擇標準。為此，許多買家正在調整籌資策略，強調供應商多元化和本地合格評估，以降低貿易波動帶來的風險。

將產品形式、聚合物選擇和特定應用要求與最終用戶的採購和認證優先事項連結起來的多維細分方法。

有效的市場區隔應明確技術要求、採購實際情況和最終用戶需求之間的交集，從而推動產品開發、供應商合作和商業化策略。在考慮一次性玻璃瓶、硬質容器和一次性包裝袋等產品類型之間的差異時，決策者必須評估每種形式如何支援無菌轉移、操作的人體工學以及與現有製程設備的整合。一次性玻璃瓶通常用作取樣和儲存工作流程中的中間容器，硬質容器可為運輸敏感材料提供更優異的機械保護，而一次性包裝袋則可提高封閉式系統中的換型效率並減輕清潔負擔。

區域供應、監管和永續性趨勢應影響全球市場生物製程容器的籌資策略和復原計畫。

區域趨勢對供應商策略、監管預期和物流複雜性有顯著影響，這些因素都應體現在採購選擇和風險緩解計畫中。在美洲，特定聚合物和薄膜領域強大的本土製造能力有助於加快合格週期並縮短前置作業時間，使買家能夠優先選擇交貨短、生產批量靈活的供應商。該地區還聚集了大量的契約製造製造商和生物製藥研發中心，推動了對擴充性的一次性解決方案和嚴格文件的需求，以滿足臨床試驗和商業化進程。

技術差異化、共同開發和供應連續性是競爭力的驅動力，它們決定了供應商的選擇和長期採購關係。

主要製造商和零件供應商之間的競爭格局主要體現在透過品質系統、技術支援和垂直整合來實現差異化。投資於材料科學、專有阻隔膜和檢驗的滅菌工藝的公司，比那些優先考慮快速認證和降低污染風險的客戶更具優勢。服務是競爭的另一個向度。能夠提供全面文件、專門的技術檢驗支援和靈活生產計劃的供應商更有可能與生物製藥公司和契約製造簽訂長期合約。

將技術、品質和採購功能整合起來的實用措施，以增強供應商的韌性，加快驗證速度，並最佳化整體擁有成本。

產業領導企業應在容器選擇流程的早期階段就採取協作方式，讓技術、品質和採購部門的相關人員參與其中，以減少下游流程中的返工和驗證延誤。協調跨職能團隊可確保規格一致性，加速供應商合格，並促進更順暢的技術轉移和規模化生產。此外，企業應優先選擇能夠提供透明文件、全面的提取和洗脫數據以及監管申報支持的供應商，以降低從臨床到商業化過渡期間的風險。

我們高度透明的混合方法研究框架，結合了二手資訊、相關人員訪談和嚴格的資料檢驗，為決策者提供可操作的見解。

本概要的研究採用了一種結構化的混合方法，旨在捕捉技術細節、商業性趨勢和區域供應的考量。研究首先對行業出版物、監管指導文件、專利申請和供應商技術文獻進行了全面的二次檢索，以整體情況容器的形狀、材料和滅菌方法。這項基準分析為後續主要研究中使用的訪談指南和定量調查問卷的製定奠定了基礎。

從全面的觀點與供應商的綜合夥伴關係、材料策略和區域採購決策如何決定營運韌性和競爭地位。

總而言之，生物製程容器產業正從商品化的供應關係轉向以技術夥伴關係、監管和供應鏈務實性為特徵的模式。材料選擇、滅菌相容性和形狀選擇如今對下游製程（例如驗證、污染控制和物流靈活性）都具有重要影響。關稅趨勢和區域產能轉移進一步加劇了採購決策的複雜性，使得供應商透明度和地理多元化對於風險管理至關重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：按容器類型分類的生物製程容器市場

  • 2D生物製程容器
  • 3D生物加工容器
  • 剛性生物製程容器
  • 專用容器
    • 玻璃瓶
    • 管瓶和安瓿

第9章：生物製程容器市場：依材料分類

  • 乙烯-醋酸乙烯酯
  • 螢光樹脂
    • 聚四氟乙烯
    • Polyvinylidene氟乙烯
  • PE多層結構
    • EVOH隔離層
    • PA/尼龍增強層
    • ULDPE/LLDPE接觸層
  • 聚丙烯
  • 聚氯乙烯

第10章：生物製程容器市場：依容量分類

  • 10-50升
  • 200-500升
  • 50-200升
  • 500-1000公升
  • 少於10公升
  • 超過1000公升

第11章：以滅菌方法分類的生物製程容器市場

  • 化學滅菌
  • 放射線殺菌
    • 電子束
    • 伽瑪射線照射
    • X光照射
  • 熱力滅菌

第12章：生物製程容器市場：依應用領域分類

  • 下游工藝
    • 層析法中間體
    • 配方
    • 收穫和澄清
    • 超過濾/透析
    • 病毒去活化
  • 灌裝/包裝
    • 原料藥的儲存
    • 最終藥品
  • 倉儲和運輸
    • 原料藥的冷凍
    • 院際轉運
  • 上游工程
    • 細胞培養與發酵
    • 培養基製備
    • 種子培養及接種物生長

第13章：生物程序容器市場：依最終用戶分類

  • 學術和研究機構
  • 生物製藥和疫苗生產商
  • 契約製造組織
  • 診斷檢測實驗室

第14章：生物程序容器市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章：生物程序容器市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：生物製程容器市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國生物製程容器市場

第18章：中國生物製程容器市場

第19章 競爭情勢

  • 2024年市場集中度分析
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2024 年
  • 2024年產品系列分析
  • 基準分析，2024 年
  • ALLpaQ Packaging Group Ltd
  • Avantor, Inc.
  • Compagnie de Saint-Gobain SA
  • Corning Incorporated
  • Cytiva by Danaher Corporation
  • Entegris, Inc.
  • Lonza Group AG
  • Meissner Corporation
  • Merck KGaA
  • Parker-Hannifin Corporation
  • Repligen Corporation
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-BB6269D136A1

The Bioprocess Containers Market was valued at USD 6.09 billion in 2024 and is projected to grow to USD 7.40 billion in 2025, with a CAGR of 22.33%, reaching USD 20.44 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 6.09 billion
Estimated Year [2025] USD 7.40 billion
Forecast Year [2030] USD 20.44 billion
CAGR (%) 22.33%

A concise orientation to the evolving role of bioprocess containers in ensuring process integrity, regulatory readiness, and operational scalability for decision-makers

The bioprocess container landscape sits at the intersection of rapid scientific progress and heightened operational scrutiny. As biologics development and manufacturing evolve, containers that historically served as passive vessels are now integral to process integrity, contamination control, and supply chain resilience. These containers support a range of activities from small-scale academic experimentation to full-scale contract manufacturing, and their selection influences process reproducibility, validation timelines, and downstream logistics.

Recent innovations in polymer science, sterilization modalities, and single-use integration have expanded the functional role of containers, prompting stakeholders to reassess procurement strategies and technical specifications. At the same time, procurement teams face increased pressure to balance cost, regulatory compliance, and environmental considerations. This dynamic compels organizations to align technical teams, quality assurance, and purchasing early in the product development lifecycle to avoid costly redesigns or qualification delays.

In this environment, a clear strategic framework helps organizations prioritize investments in container technologies that enable scalability, reduce contamination risk, and simplify validation. This summary synthesizes the forces shaping vendor selection, material choice, application-specific requirements, and regional supply dynamics to guide leaders who must make timely, defensible decisions across research, clinical, and commercial operations.

Key structural and technological inflection points that are reshaping supplier dynamics, material priorities, and regulatory expectations across bioprocess container usage

The landscape for bioprocess containers is undergoing several transformative shifts that are redefining supplier relationships, design priorities, and procurement logic. First, the migration toward single-use systems and hybrid processing has accelerated, forcing manufacturers and integrators to emphasize component compatibility, connector standardization, and supply continuity. This evolution is reshaping how pharmaceutical developers approach process transfer and technology qualification, with downstream effects on validation strategies and vendor audits.

Second, material science advances are driving differentiation through films and polymers engineered for extractables and leachables performance, mechanical resilience, and sterilization tolerance. As a result, specifications are increasingly granular, and cross-functional teams must codify acceptance criteria earlier in development. Third, regulatory scrutiny over contamination control and supply chain traceability has intensified, prompting more rigorous documentation and supplier transparency requirements. This is prompting many organizations to demand enhanced quality agreements, chain-of-custody records, and batch-specific certification.

Fourth, commercialization pathways and contract manufacturing models are compelling end users to prioritize containers that enable rapid scale-up while minimizing requalification. Finally, environmental and circularity considerations are nudging manufacturers to explore recyclable polymers and take-back programs, though economic and technical barriers remain. Together, these shifts demand that stakeholders adopt proactive supply strategies, integrate technical and procurement decision-making, and remain adaptable to rapid technological and regulatory change.

How 2025 tariff developments are recalibrating sourcing choices, supplier qualification imperatives, and supply chain resilience strategies across the bioprocess container value chain

Tariff actions and trade policy changes announced in 2025 have a multilayered effect on the bioprocess container ecosystem, influencing sourcing decisions, cost structures, and supplier footprint planning. For organizations that rely on cross-border supply chains, increased duties raise the effective landed cost of imported components and finished containers, which in turn pressures margins or forces buyers to reconsider supplier selection criteria. In response, several buyers are recalibrating procurement strategies to emphasize vendor diversification and local qualification to reduce exposure to trade volatility.

The tariff environment also affects component suppliers differently depending on material composition and manufacturing location. Manufacturers that rely on imported resin feedstocks or specialized films can experience higher input costs that cascade along the value chain, prompting renegotiation of supply contracts or exploration of alternative feedstock sources. Concurrently, manufacturers with domestic production capabilities may leverage nearshoring as a competitive advantage, offering shorter lead times and reduced exposure to cross-border friction, which has become an increasingly important selection factor during qualification.

Beyond immediate cost pressure, tariffs can accelerate structural changes such as strategic partnerships, joint ventures, and capacity investments in import-competing geographies. Buyers must weigh the benefits of cost predictability and supply resilience against the potential need for revalidation when qualifying new suppliers or materials. Ultimately, the cumulative impact of tariff shifts underscores the importance of scenario planning, robust supplier qualification processes, and the integration of trade considerations into technical decision-making.

A multidimensional segmentation approach linking product formats, polymer choices, and application-specific demands to procurement and qualification priorities for end users

Effective segmentation illuminates where technical requirements intersect with procurement realities and end-user needs, and it should drive product development, supplier engagement, and commercialization strategies. When considering product type distinctions such as Disposable Carboys, Rigid Containers, and Single-Use Bags, decision-makers must evaluate how each format supports aseptic transfer, handling ergonomics, and integration with existing process skids. Disposable Carboys often serve as intermediary vessels in sampling and storage workflows; rigid containers can offer superior mechanical protection for transport-sensitive materials; and single-use bags enable leaner changeover and reduced cleaning burden for closed systems.

Material choice is another critical axis: Polyethylene, Polypropylene, and Polyvinyl Chloride each offer unique chemical resistance, flexibility, and thermal tolerance that affect sterilization compatibility and extractables profiles. Polyethylene and polypropylene variants are commonly selected for single-use applications due to favorable weldability and low extractables, while polyvinyl chloride still finds use where flexibility and cost considerations dominate. Application-specific segmentation further refines requirements. In Cell Culture applications-covering Insect Culture, Mammalian Culture, and Microbial Culture-biological sensitivity and nutrient compositions dictate container surface treatments, gas transfer considerations, and cleanliness thresholds. Fermentation use cases split between Cell-Based Fermentation and Microbial Fermentation, each presenting divergent shear, mixing, and sampling demands. Sampling and Storage & Transport use cases emphasize container closure integrity, labeling, and traceability.

End-user type shapes procurement lead times, documentation expectations, and volume patterns. Academic & Research Institutes, which include Government Research Institutes and University Laboratories, prioritize flexibility, short-run availability, and cost-effective validation, while Biopharmaceutical Companies demand rigorous quality systems, vendor audits, and long-term supply commitments. Contract Manufacturing Organizations require containers that support rapid changeover, validated interchangeability, and consistent lot-to-lot performance. Capacity segmentation-ranging from Up To 50 Liters to 50 To 200 Liters and Above 200 Liters-further dictates material thickness, port configuration, and handling requirements. Sterilization method selection, whether Autoclavable, EtO Sterilization, or Gamma Sterilization, imposes material and design constraints that must be reconciled with extractables, packaging, and labeling protocols. Together, these segmentation lenses create a multidimensional specification matrix that manufacturers and purchasers must navigate when matching container solutions to process needs.

Regional supply, regulatory, and sustainability dynamics that should shape sourcing strategies and resilience planning for bioprocess container procurement across global markets

Regional dynamics exert material influence on supplier strategies, regulatory expectations, and logistical complexity, and they should inform both sourcing choices and risk mitigation planning. In the Americas, strong domestic manufacturing capacity in certain polymer and film categories supports quicker qualification cycles and shorter lead times, creating opportunities for buyers to prioritize suppliers capable of near-term delivery and flexible production runs. This region also exhibits a high density of contract manufacturers and biopharmaceutical development centers, increasing demand for scalable single-use solutions and rigorous documentation to meet clinical and commercialization timelines.

Europe, Middle East & Africa presents a heterogeneous set of market drivers where regulatory frameworks and environmental policy considerations vary across jurisdictions. In many European markets, heightened emphasis on sustainability and extended producer responsibility drives buyer interest in recyclable materials and circularity pilots, while regulatory agencies expect comprehensive extractables and leachables data for sterile processing components. The Middle East and Africa show growing demand driven by capacity expansion and investment in local manufacturing, but limited local supplier ecosystems often result in reliance on imports and longer qualification lead times.

Asia-Pacific remains a strategic focal point due to its large-scale manufacturing base, rapid capacity additions, and a deep supplier network for polymers and finished components. Procurement teams often find competitive pricing and breadth of options in this region, yet they must balance cost advantages against potential trade policy exposure and variable quality systems. Across all regions, logistics constraints, customs practices, and regional sterilization capabilities affect selection and inventory strategy, so cross-geography sourcing strategies must account for both technical compatibility and operational resilience.

Competitive dynamics driven by technical differentiation, collaborative development, and supply continuity that determine supplier selection and long-term procurement relationships

Competitive dynamics among leading manufacturers and component suppliers center on differentiation through quality systems, technical support, and vertical integration. Companies that invest in material science, proprietary barrier films, and validated sterilization processes gain an edge with customers that prioritize rapid qualification and reduced contamination risk. Another axis of competition is service: suppliers that provide comprehensive documentation, dedicated technical validation support, and flexible production scheduling are more likely to secure long-term agreements with biopharmaceutical firms and contract manufacturers.

Strategic partnerships and collaborative development agreements are increasingly common as suppliers seek to embed their products earlier in client development pipelines. These relationships can include co-development of customized container formats, joint extractables and leachables testing, and coordinated regulatory submissions that streamline client adoption. Additionally, some suppliers are vertically integrating resin supply or film extrusion capabilities to control input quality and reduce lead time variability, which appeals to buyers focused on continuity and traceability.

Mergers and acquisitions remain a tactical option for companies seeking scale, expanded geographic footprint, or complementary technology stacks. However, customers are more sensitive to continuity of supply during integration periods, so transparency about capacity planning and quality control during transactional transitions is critical. Ultimately, the competitive landscape favors suppliers that combine robust quality systems, technical partnership willingness, and responsive supply chain management.

Actionable measures for integrating technical, quality, and procurement functions to enhance supplier resilience, accelerate validation, and optimize total cost of ownership

Industry leaders should adopt a coordinated approach that embeds technical, quality, and procurement stakeholders early in the container selection process to reduce downstream rework and validation delays. Aligning cross-functional teams ensures specification convergence and accelerates supplier qualification, enabling smoother technology transfer and scale-up. Additionally, firms should prioritize suppliers that offer transparent documentation, comprehensive extractables and leachables data, and support for regulatory submissions to reduce risk during clinical and commercial transitions.

To strengthen supply resilience, diversify the supplier base across geographies and technologies while maintaining a small set of fully qualified alternate vendors. This dual strategy preserves negotiation leverage and reduces dependence on a single manufacturing node without overwhelming validation capacities. Invest in supplier performance metrics and cadence-based reviews to identify emerging capacity constraints early, and incorporate trade policy scenario planning into procurement decision frameworks.

On the technical front, prioritize materials and designs compatible with multiple sterilization methods where feasible, as this flexibility can simplify qualification across manufacturing sites and reduce bottlenecks. Evaluate opportunities for pilot partnerships focused on recyclability and lifecycle management where regional policy or customer demands make circularity a near-term priority. Finally, integrate tariff and trade considerations into total-cost-of-ownership models to ensure procurement decisions reflect landed cost, risk, and validation overhead rather than unit price alone.

A transparent mixed-methods research framework combining secondary intelligence, stakeholder interviews, and rigorous data validation to support actionable insights for decision-makers

The research behind this summary employed a structured mixed-methods approach designed to capture technical nuance, commercial dynamics, and regional supply considerations. The process began with a comprehensive secondary review of industry publications, regulatory guidance documents, patent filings, and supplier technical literature to map the landscape of container formats, materials, and sterilization methods. This baseline analysis informed the development of interview guides and quantitative questionnaires used during primary research.

Primary research included interviews with senior technical leaders, quality assurance professionals, procurement officers, and manufacturing specialists across end-user segments including academic institutions, biopharmaceutical companies, and contract manufacturers. These conversations elicited information on specification priorities, qualification timelines, supplier evaluation criteria, and logistical constraints. To validate findings, triangulation was applied by cross-referencing interview insights with supplier documentation and observed procurement patterns.

Analytical rigor was maintained through standardized coding of qualitative data, quality checks on supplier claims, and peer review of interpretations by subject-matter experts. Limitations include the evolving nature of trade policy and the variability of regional sterilization infrastructure, which may change rapidly. To mitigate these risks, the methodology emphasizes scenario-based analysis and supplier performance indicators that can be updated as new data emerges.

A summative perspective on how integrated supplier partnerships, material strategy, and regional sourcing decisions together determine operational resilience and competitive positioning

In summary, the bioprocess container sector is transitioning from a commoditized supply relationship to one characterized by technical partnerships, regulatory scrutiny, and supply chain pragmatism. Material selection, sterilization compatibility, and format choice now carry downstream implications for validation, contamination control, and logistical agility. Tariff developments and regional capacity shifts further complicate procurement decisions, making supplier transparency and geographic diversification essential to risk management.

Organizations that proactively align cross-functional stakeholders, qualify alternate suppliers, and prioritize containers compatible with multiple sterilization pathways will be better positioned to navigate both technical and commercial uncertainties. Strategic investment in supplier partnerships and material innovation can yield operational advantages, while thoughtful incorporation of trade and regional dynamics into procurement models will reduce exposure to sudden cost or lead-time shocks. Ultimately, the most resilient organizations will be those that treat container selection as an integrated strategic decision, not simply a purchasing execution, thereby converting supply chain complexity into a competitive advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2024
  • 3.5. FPNV Positioning Matrix, 2024
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bioprocess Containers Market, by Container Type

  • 8.1. 2D Bioprocess Containers
  • 8.2. 3D Bioprocess Containers
  • 8.3. Rigid Bioprocess Containers
  • 8.4. Specialty Containers
    • 8.4.1. Carboys & Bottles
    • 8.4.2. Vials & Ampoules

9. Bioprocess Containers Market, by Material

  • 9.1. Ethylene Vinyl Acetate
  • 9.2. Fluoropolymers
    • 9.2.1. Polytetrafluoroethylene
    • 9.2.2. Polyvinylidene Fluoride
  • 9.3. PE-Based Multilayer
    • 9.3.1. EVOH Barrier Layer
    • 9.3.2. PA/Nylon Reinforcement Layer
    • 9.3.3. ULDPE/LLDPE Contact Layer
  • 9.4. Polypropylene
  • 9.5. Polyvinyl Chloride

10. Bioprocess Containers Market, by Capacity

  • 10.1. 10-50 Liters
  • 10.2. 200 - 500 Liters
  • 10.3. 50 - 200 Liters
  • 10.4. 500 - 1000 Liters
  • 10.5. < 10 Liters
  • 10.6. > 1000 Liters

11. Bioprocess Containers Market, by Sterilization Method

  • 11.1. Chemical Sterilization
  • 11.2. Radiation-Based Sterilization
    • 11.2.1. Electron Beam
    • 11.2.2. Gamma Irradiation
    • 11.2.3. X-Ray Irradiation
  • 11.3. Thermal Sterilization

12. Bioprocess Containers Market, by Application

  • 12.1. Downstream Processing
    • 12.1.1. Chromatography Intermediates
    • 12.1.2. Formulation
    • 12.1.3. Harvest & Clarification
    • 12.1.4. Ultrafiltration/Diafiltration
    • 12.1.5. Viral Inactivation
  • 12.2. Fill-Finish
    • 12.2.1. Bulk Drug Substance Storage
    • 12.2.2. Final Drug Product
  • 12.3. Storage & Transport
    • 12.3.1. Drug Substance Freezing
    • 12.3.2. Inter-Facility Transfer
  • 12.4. Upstream Processing
    • 12.4.1. Cell Culture & Fermentation
    • 12.4.2. Media Preparation
    • 12.4.3. Seed Train & Inoculum Expansion

13. Bioprocess Containers Market, by End User

  • 13.1. Academic & Research Institutes
  • 13.2. Biopharmaceutical & Vaccine Manufacturers
  • 13.3. Contract Manufacturing Organizations
  • 13.4. Diagnostic Laboratories

14. Bioprocess Containers Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Bioprocess Containers Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Bioprocess Containers Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Bioprocess Containers Market

18. China Bioprocess Containers Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2024
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2024
  • 19.3. Product Portfolio Analysis, 2024
  • 19.4. Benchmarking Analysis, 2024
  • 19.5. ALLpaQ Packaging Group Ltd
  • 19.6. Avantor, Inc.
  • 19.7. Compagnie de Saint-Gobain S.A.
  • 19.8. Corning Incorporated
  • 19.9. Cytiva by Danaher Corporation
  • 19.10. Entegris, Inc.
  • 19.11. Lonza Group AG
  • 19.12. Meissner Corporation
  • 19.13. Merck KGaA
  • 19.14. Parker-Hannifin Corporation
  • 19.15. Repligen Corporation
  • 19.16. Sartorius AG
  • 19.17. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 2. GLOBAL BIOPROCESS CONTAINERS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 3. GLOBAL BIOPROCESS CONTAINERS MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 4. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CONTAINER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CAPACITY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY STERILIZATION METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES BIOPROCESS CONTAINERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 14. CHINA BIOPROCESS CONTAINERS MARKET SIZE, 2018-2030 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 2. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CONTAINER TYPE, 2018-2030 (USD MILLION)
  • TABLE 3. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 2D BIOPROCESS CONTAINERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 2D BIOPROCESS CONTAINERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 2D BIOPROCESS CONTAINERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 3D BIOPROCESS CONTAINERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 3D BIOPROCESS CONTAINERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 3D BIOPROCESS CONTAINERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY RIGID BIOPROCESS CONTAINERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY RIGID BIOPROCESS CONTAINERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY RIGID BIOPROCESS CONTAINERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY SPECIALTY CONTAINERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY SPECIALTY CONTAINERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY SPECIALTY CONTAINERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY SPECIALTY CONTAINERS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CARBOYS & BOTTLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CARBOYS & BOTTLES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CARBOYS & BOTTLES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY VIALS & AMPOULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY VIALS & AMPOULES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY VIALS & AMPOULES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY FLUOROPOLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY FLUOROPOLYMERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY FLUOROPOLYMERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY FLUOROPOLYMERS, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY POLYVINYLIDENE FLUORIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY POLYVINYLIDENE FLUORIDE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY POLYVINYLIDENE FLUORIDE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY PE-BASED MULTILAYER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY PE-BASED MULTILAYER, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY PE-BASED MULTILAYER, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY PE-BASED MULTILAYER, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY EVOH BARRIER LAYER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY EVOH BARRIER LAYER, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY EVOH BARRIER LAYER, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY PA/NYLON REINFORCEMENT LAYER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY PA/NYLON REINFORCEMENT LAYER, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY PA/NYLON REINFORCEMENT LAYER, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY ULDPE/LLDPE CONTACT LAYER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY ULDPE/LLDPE CONTACT LAYER, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY ULDPE/LLDPE CONTACT LAYER, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY POLYVINYL CHLORIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY POLYVINYL CHLORIDE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY POLYVINYL CHLORIDE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 10-50 LITERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 10-50 LITERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 10-50 LITERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 200 - 500 LITERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 200 - 500 LITERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 200 - 500 LITERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 50 - 200 LITERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 50 - 200 LITERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 50 - 200 LITERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 500 - 1000 LITERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 66. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 500 - 1000 LITERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 67. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 500 - 1000 LITERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 68. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY < 10 LITERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 69. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY < 10 LITERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 70. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY < 10 LITERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 71. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY > 1000 LITERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 72. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY > 1000 LITERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 73. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY > 1000 LITERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 74. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 75. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CHEMICAL STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 76. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CHEMICAL STERILIZATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 77. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CHEMICAL STERILIZATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 78. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY RADIATION-BASED STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 79. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY RADIATION-BASED STERILIZATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 80. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY RADIATION-BASED STERILIZATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY RADIATION-BASED STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 82. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY ELECTRON BEAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 83. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY ELECTRON BEAM, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 84. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY ELECTRON BEAM, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY GAMMA IRRADIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 86. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY GAMMA IRRADIATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 87. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY GAMMA IRRADIATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 88. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY X-RAY IRRADIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 89. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY X-RAY IRRADIATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 90. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY X-RAY IRRADIATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 91. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY THERMAL STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 92. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY THERMAL STERILIZATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 93. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY THERMAL STERILIZATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 94. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 96. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY DOWNSTREAM PROCESSING, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 97. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY DOWNSTREAM PROCESSING, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 98. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 99. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CHROMATOGRAPHY INTERMEDIATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 100. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CHROMATOGRAPHY INTERMEDIATES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 101. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CHROMATOGRAPHY INTERMEDIATES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 102. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY FORMULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 103. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY FORMULATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 104. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY FORMULATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY HARVEST & CLARIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 106. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY HARVEST & CLARIFICATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 107. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY HARVEST & CLARIFICATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY ULTRAFILTRATION/DIAFILTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 109. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY ULTRAFILTRATION/DIAFILTRATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 110. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY ULTRAFILTRATION/DIAFILTRATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 111. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY VIRAL INACTIVATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 112. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY VIRAL INACTIVATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 113. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY VIRAL INACTIVATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 114. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY FILL-FINISH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 115. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY FILL-FINISH, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 116. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY FILL-FINISH, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 117. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY FILL-FINISH, 2018-2030 (USD MILLION)
  • TABLE 118. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY BULK DRUG SUBSTANCE STORAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 119. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY BULK DRUG SUBSTANCE STORAGE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 120. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY BULK DRUG SUBSTANCE STORAGE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 121. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY FINAL DRUG PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 122. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY FINAL DRUG PRODUCT, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 123. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY FINAL DRUG PRODUCT, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 124. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY STORAGE & TRANSPORT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 125. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY STORAGE & TRANSPORT, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 126. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY STORAGE & TRANSPORT, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 127. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY STORAGE & TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 128. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY DRUG SUBSTANCE FREEZING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 129. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY DRUG SUBSTANCE FREEZING, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 130. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY DRUG SUBSTANCE FREEZING, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY INTER-FACILITY TRANSFER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 132. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY INTER-FACILITY TRANSFER, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 133. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY INTER-FACILITY TRANSFER, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 134. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 135. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY UPSTREAM PROCESSING, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 136. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY UPSTREAM PROCESSING, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 137. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 138. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CELL CULTURE & FERMENTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 139. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CELL CULTURE & FERMENTATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 140. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CELL CULTURE & FERMENTATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 141. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY MEDIA PREPARATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 142. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY MEDIA PREPARATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 143. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY MEDIA PREPARATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 144. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY SEED TRAIN & INOCULUM EXPANSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 145. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY SEED TRAIN & INOCULUM EXPANSION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 146. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY SEED TRAIN & INOCULUM EXPANSION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 147. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 149. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 150. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 151. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY BIOPHARMACEUTICAL & VACCINE MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 152. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY BIOPHARMACEUTICAL & VACCINE MANUFACTURERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 153. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY BIOPHARMACEUTICAL & VACCINE MANUFACTURERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 154. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 155. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 156. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 157. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 158. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 159. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 160. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 161. AMERICAS BIOPROCESS CONTAINERS MARKET SIZE, BY SUBREGION, 2018-2030 (USD MILLION)
  • TABLE 162. AMERICAS BIOPROCESS CONTAINERS MARKET SIZE, BY CONTAINER TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. AMERICAS BIOPROCESS CONTAINERS MARKET SIZE, BY SPECIALTY CONTAINERS, 2018-2030 (USD MILLION)
  • TABLE 164. AMERICAS BIOPROCESS CONTAINERS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 165. AMERICAS BIOPROCESS CONTAINERS MARKET SIZE, BY FLUOROPOLYMERS, 2018-2030 (USD MILLION)
  • TABLE 166. AMERICAS BIOPROCESS CONTAINERS MARKET SIZE, BY PE-BASED MULTILAYER, 2018-2030 (USD MILLION)
  • TABLE 167. AMERICAS BIOPROCESS CONTAINERS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 168. AMERICAS BIOPROCESS CONTAINERS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 169. AMERICAS BIOPROCESS CONTAINERS MARKET SIZE, BY RADIATION-BASED STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 170. AMERICAS BIOPROCESS CONTAINERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. AMERICAS BIOPROCESS CONTAINERS MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 172. AMERICAS BIOPROCESS CONTAINERS MARKET SIZE, BY FILL-FINISH, 2018-2030 (USD MILLION)
  • TABLE 173. AMERICAS BIOPROCESS CONTAINERS MARKET SIZE, BY STORAGE & TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 174. AMERICAS BIOPROCESS CONTAINERS MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 175. AMERICAS BIOPROCESS CONTAINERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. NORTH AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 177. NORTH AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY CONTAINER TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. NORTH AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY SPECIALTY CONTAINERS, 2018-2030 (USD MILLION)
  • TABLE 179. NORTH AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 180. NORTH AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY FLUOROPOLYMERS, 2018-2030 (USD MILLION)
  • TABLE 181. NORTH AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY PE-BASED MULTILAYER, 2018-2030 (USD MILLION)
  • TABLE 182. NORTH AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 183. NORTH AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 184. NORTH AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY RADIATION-BASED STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 185. NORTH AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. NORTH AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 187. NORTH AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY FILL-FINISH, 2018-2030 (USD MILLION)
  • TABLE 188. NORTH AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY STORAGE & TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 189. NORTH AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 190. NORTH AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. LATIN AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 192. LATIN AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY CONTAINER TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. LATIN AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY SPECIALTY CONTAINERS, 2018-2030 (USD MILLION)
  • TABLE 194. LATIN AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 195. LATIN AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY FLUOROPOLYMERS, 2018-2030 (USD MILLION)
  • TABLE 196. LATIN AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY PE-BASED MULTILAYER, 2018-2030 (USD MILLION)
  • TABLE 197. LATIN AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 198. LATIN AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 199. LATIN AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY RADIATION-BASED STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 200. LATIN AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. LATIN AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 202. LATIN AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY FILL-FINISH, 2018-2030 (USD MILLION)
  • TABLE 203. LATIN AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY STORAGE & TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 204. LATIN AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 205. LATIN AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY SUBREGION, 2018-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY CONTAINER TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY SPECIALTY CONTAINERS, 2018-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY FLUOROPOLYMERS, 2018-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY PE-BASED MULTILAYER, 2018-2030 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY RADIATION-BASED STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY FILL-FINISH, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY STORAGE & TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE BIOPROCESS CONTAINERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE BIOPROCESS CONTAINERS MARKET SIZE, BY CONTAINER TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE BIOPROCESS CONTAINERS MARKET SIZE, BY SPECIALTY CONTAINERS, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE BIOPROCESS CONTAINERS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 225. EUROPE BIOPROCESS CONTAINERS MARKET SIZE, BY FLUOROPOLYMERS, 2018-2030 (USD MILLION)
  • TABLE 226. EUROPE BIOPROCESS CONTAINERS MARKET SIZE, BY PE-BASED MULTILAYER, 2018-2030 (USD MILLION)
  • TABLE 227. EUROPE BIOPROCESS CONTAINERS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 228. EUROPE BIOPROCESS CONTAINERS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 229. EUROPE BIOPROCESS CONTAINERS MARKET SIZE, BY RADIATION-BASED STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 230. EUROPE BIOPROCESS CONTAINERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. EUROPE BIOPROCESS CONTAINERS MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 232. EUROPE BIOPROCESS CONTAINERS MARKET SIZE, BY FILL-FINISH, 2018-2030 (USD MILLION)
  • TABLE 233. EUROPE BIOPROCESS CONTAINERS MARKET SIZE, BY STORAGE & TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 234. EUROPE BIOPROCESS CONTAINERS MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 235. EUROPE BIOPROCESS CONTAINERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 236. MIDDLE EAST BIOPROCESS CONTAINERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 237. MIDDLE EAST BIOPROCESS CONTAINERS MARKET SIZE, BY CONTAINER TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. MIDDLE EAST BIOPROCESS CONTAINERS MARKET SIZE, BY SPECIALTY CONTAINERS, 2018-2030 (USD MILLION)
  • TABLE 239. MIDDLE EAST BIOPROCESS CONTAINERS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 240. MIDDLE EAST BIOPROCESS CONTAINERS MARKET SIZE, BY FLUOROPOLYMERS, 2018-2030 (USD MILLION)
  • TABLE 241. MIDDLE EAST BIOPROCESS CONTAINERS MARKET SIZE, BY PE-BASED MULTILAYER, 2018-2030 (USD MILLION)
  • TABLE 242. MIDDLE EAST BIOPROCESS CONTAINERS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 243. MIDDLE EAST BIOPROCESS CONTAINERS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 244. MIDDLE EAST BIOPROCESS CONTAINERS MARKET SIZE, BY RADIATION-BASED STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 245. MIDDLE EAST BIOPROCESS CONTAINERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. MIDDLE EAST BIOPROCESS CONTAINERS MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 247. MIDDLE EAST BIOPROCESS CONTAINERS MARKET SIZE, BY FILL-FINISH, 2018-2030 (USD MILLION)
  • TABLE 248. MIDDLE EAST BIOPROCESS CONTAINERS MARKET SIZE, BY STORAGE & TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 249. MIDDLE EAST BIOPROCESS CONTAINERS MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 250. MIDDLE EAST BIOPROCESS CONTAINERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 251. AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 252. AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY CONTAINER TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY SPECIALTY CONTAINERS, 2018-2030 (USD MILLION)
  • TABLE 254. AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 255. AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY FLUOROPOLYMERS, 2018-2030 (USD MILLION)
  • TABLE 256. AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY PE-BASED MULTILAYER, 2018-2030 (USD MILLION)
  • TABLE 257. AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 258. AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 259. AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY RADIATION-BASED STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 260. AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 261. AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 262. AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY FILL-FINISH, 2018-2030 (USD MILLION)
  • TABLE 263. AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY STORAGE & TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 264. AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 265. AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC BIOPROCESS CONTAINERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC BIOPROCESS CONTAINERS MARKET SIZE, BY CONTAINER TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC BIOPROCESS CONTAINERS MARKET SIZE, BY SPECIALTY CONTAINERS, 2018-2030 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC BIOPROCESS CONTAINERS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC BIOPROCESS CONTAINERS MARKET SIZE, BY FLUOROPOLYMERS, 2018-2030 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC BIOPROCESS CONTAINERS MARKET SIZE, BY PE-BASED MULTILAYER, 2018-2030 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC BIOPROCESS CONTAINERS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC BIOPROCESS CONTAINERS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC BIOPROCESS CONTAINERS MARKET SIZE, BY RADIATION-BASED STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC BIOPROCESS CONTAINERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC BIOPROCESS CONTAINERS MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC BIOPROCESS CONTAINERS MARKET SIZE, BY FILL-FINISH, 2018-2030 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC BIOPROCESS CONTAINERS MARKET SIZE, BY STORAGE & TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC BIOPROCESS CONTAINERS MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC BIOPROCESS CONTAINERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 281. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 282. ASEAN BIOPROCESS CONTAINERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 283. ASEAN BIOPROCESS CONTAINERS MARKET SIZE, BY CONTAINER TYPE, 2018-2030 (USD MILLION)
  • TABLE 284. ASEAN BIOPROCESS CONTAINERS MARKET SIZE, BY SPECIALTY CONTAINERS, 2018-2030 (USD MILLION)
  • TABLE 285. ASEAN BIOPROCESS CONTAINERS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 286. ASEAN BIOPROCESS CONTAINERS MARKET SIZE, BY FLUOROPOLYMERS, 2018-2030 (USD MILLION)
  • TABLE 287. ASEAN BIOPROCESS CONTAINERS MARKET SIZE, BY PE-BASED MULTILAYER, 2018-2030 (USD MILLION)
  • TABLE 288. ASEAN BIOPROCESS CONTAINERS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 289. ASEAN BIOPROCESS CONTAINERS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 290. ASEAN BIOPROCESS CONTAINERS MARKET SIZE, BY RADIATION-BASED STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 291. ASEAN BIOPROCESS CONTAINERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 292. ASEAN BIOPROCESS CONTAINERS MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 293. ASEAN BIOPROCESS CONTAINERS MARKET SIZE, BY FILL-FINISH, 2018-2030 (USD MILLION)
  • TABLE 294. ASEAN BIOPROCESS CONTAINERS MARKET SIZE, BY STORAGE & TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 295. ASEAN BIOPROCESS CONTAINERS MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 296. ASEAN BIOPROCESS CONTAINERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 297. GCC BIOPROCESS CONTAINERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 298. GCC BIOPROCESS CONTAINERS MARKET SIZE, BY CONTAINER TYPE, 2018-2030 (USD MILLION)
  • TABLE 299. GCC BIOPROCESS CONTAINERS MARKET SIZE, BY SPECIALTY CONTAINERS, 2018-2030 (USD MILLION)
  • TABLE 300. GCC BIOPROCESS CONTAINERS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 301. GCC BIOPROCESS CONTAINERS MARKET SIZE, BY FLUOROPOLYMERS, 2018-2030 (USD MILLION)
  • TABLE 302. GCC BIOPROCESS CONTAINERS MARKET SIZE, BY PE-BASED MULTILAYER, 2018-2030 (USD MILLION)
  • TABLE 303. GCC BIOPROCESS CONTAINERS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 304. GCC BIOPROCESS CONTAINERS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 305. GCC BIOPROCESS CONTAINERS MARKET SIZE, BY RADIATION-BASED STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 306. GCC BIOPROCESS CONTAINERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 307. GCC BIOPROCESS CONTAINERS MARKET SIZ